Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00543ApprovedSmall moleculeAntidepressive Agents Indicated for DepressionAntidepressive Agents, Tricyclic
Amoxapine is a tricyclic antidepressant used in the treatment of neurotic or reactive depressive disorders and endogenous or psychotic depression. Amoxapine, the N-demethylated derivative of the antipsychotic agent loxapine, is a dibenzoxazepine-derivative tricyclic antidepressant (TCA).
- Mechanism
- Curator reviewed
Amoxapine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT).
- Primary indication
- For the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions.Curator reviewed · 6 structured indications
- Formula / weight
- C17H16ClN3O · 313.781 g/mol (avg)
- First approval
- Canada, 1981 · United States, 1991
- Also known as
- Desmethylloxapin
- Code names
- CL-67,772
Resolves to
Clinical / RWD
Structure
InChIKey
QWGDMFLQWFTERH-UHFFFAOYSA-NSMILESClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1What you can answer from here — as of September 20, 2026
26Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Amoxapine, and which of those have an active Phase 3 trial?